Reuters reported:
Private equity firm Carlyle Group Inc (CG.O) has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc (MDT.N) at a valuation of more than $7 billion, according to people familiar with the matter.
Were an agreement to be reached in the coming weeks, it would mark the culmination of Medtronic's 12-month review of its patient monitoring and respiratory interventions businesses.
Given Carlyle's ability to cross sell within its affiliate pool, what can a healthcare patient expect? How about some music?
Litmus Music — a music catalog rights company backed by private-equity firm Carlyle Group LP
Maybe some respiratory therapy intervention dancing to Katy Perry or Keith Urban?
Carlyle drove two post acute care companies into bankruptcy, nursing home giant ManorCare and long term acute care hospital company LifeCare, so those cross selling options have closed for the politically connected private equity underwriter (PEU).
Rest assured the greed and leverage boys will continue to crapify healthcare. Profit over patients, it's in their nature.
Politicians Red and Blue love PEU, and that's why so many parasitic PEUs are deep in healthcare. The PEU boys love the security of Uncle Sam's wallet!
Update 1-3-24: NakedCapitalism did a great piece on the PEU boys bleeding healthcare firms and harming quality care.
